Sign up Calendar Latest Topics
 
 
 


Reply
  Author   Comment  
SoCalLisa

Avatar / Picture

Goddess Forever
Registered:
Posts: 2,134
Reply with quote  #1 
Hi all..I read this today and it goes way back to 2001
but what is this all about???


To Print: Click your browser's PRINT button.
NOTE: To view the article with Web enhancements, go to:
http://www.medscape.com/medline/abstract
 

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.

Proc Natl Acad Sci U S A.  2001; 98(19):10869-74 (ISSN: 0027-8424)

Sørlie T ; Perou CM ; Tibshirani R ; Aas T ; Geisler S ; Johnsen H ; Hastie T ; Eisen MB ; van de Rijn M ; Jeffrey SS ; Thorsen T ; Quist H ; Matese JC ; Brown PO ; Botstein D ; Eystein Lønning P ; Børresen-Dale AL
Department of Genetics, The Norwegian Radium Hospital, Montebello, N-0310 Oslo, Norway.

The purpose of this study was to classify breast carcinomas based on variations in gene expression patterns derived from cDNA microarrays and to correlate tumor characteristics to clinical outcome. A total of 85 cDNA microarray experiments representing 78 cancers, three fibroadenomas, and four normal breast tissues were analyzed by hierarchical clustering. As reported previously, the cancers could be classified into a basal epithelial-like group, an ERBB2-overexpressing group and a normal breast-like group based on variations in gene expression. A novel finding was that the previously characterized luminal epithelial/estrogen receptor-positive group could be divided into at least two subgroups, each with a distinctive expression profile. These subtypes proved to be reasonably robust by clustering using two different gene sets: first, a set of 456 cDNA clones previously selected to reflect intrinsic properties of the tumors and, second, a gene set that highly correlated with patient outcome. Survival analyses on a subcohort of patients with locally advanced breast cancer uniformly treated in a prospective study showed significantly different outcomes for the patients belonging to the various groups, including a poor prognosis for the basal-like subtype and a significant difference in outcome for the two estrogen receptor-positive groups.

  • PreMedline Identifier: 11553815
 

__________________
"One's mind, once stretched by a new idea, never regains its original dimensions."
-Oliver Wendell Holmes
Previous Topic | Next Topic
Print
Reply

Quick Navigation:

Easily create a Forum Website with Website Toolbox.